Growth hormone deficiency and pituitary stalk interruption in Fanconi anemia;Déficit en GH par interruption de la tige pituitaire dans l'anémie de Fanconi

Annales d'Endocrinologie

Volumn 69, Issue 1, 2008, Pages 63-68

  Lamine, F ^a   Turki, Z ^a   Mrad, R ^b   Ben Salem, L ^a   Ben Hafsa, I ^a   Akrout, S ^a   Ben Slama, C ^a  

^a Institut National de Nutrition Tunis   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Fanconi anemia; Growth hormone deficiency; Pituitary stalk interruption syndrome

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; INSULIN; RISEDRONIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOSOMAL DISORDER; CANCER RISK; CASE REPORT; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CONGENITAL MALFORMATION; CROSS LINKING; DISEASE ASSOCIATION; FANCONI ANEMIA; FEMALE; FRAGILITY FRACTURE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPITUITARISM; INFUNDIBULUM; MORBIDITY; PANCYTOPENIA; PRIMARY AMENORRHEA; RARE DISEASE; SOLID TUMOR; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AMENORRHEA; DWARFISM, PITUITARY; FANCONI ANEMIA; FEMALE; HUMAN GROWTH HORMONE; HUMANS; PITUITARY GLAND; POLYDACTYLY;

EID: 41549134614     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.10.001     Document Type: Article

References (27)

1. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 2 (2003) 425-440
2. Aynsley-Green A., Zachmann M., Werder E.A., et al. Endocrine studies in Fanconi anemia. Arch. Dis. Child. 2 (1978) 126-131
3. Berkovitz G.D., Zinkham W., and Migeon C.J. Gonadal function in two siblings with Fanconi's anemia. Horm. Res. 19 (1984) 137-141
4. Bouchlaka C., Abdelhak S., Dellagi K., and pour le groupe d'étude de la maladie de Fanconi en Tunisie. Étude moléculaire de l'anémie de Fanconi en Tunisie. Tun. Med. 82 (2004) 402-410
5. Cohen L.E., and Dadovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr. Rev. 23 (2002) 431-442
6. Coutant R., and Carel J.C. Le diagnostic du déficit en hormone de croissance chez l'enfant. mt endocrinologie 4 (2002) 25-32
7. D'Andrea A., and Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood 90 (1997) 1725-1736
8. Depuis-Girod S., Gluckman E., Souberbelle J.C., et al. Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia. J. Pediatr. 138 (2001) 129-133
9. Frikha M., Mseddi S., Elloumi M., et al. La maladie de Fanconi : étude de 43 cas dans le sud tunisien. Arch. Pediatr. 5 (1998) 1200-1205
10. Guardiola P., Socie G., Pasquini R., et al. Allogenic stem cell transplantation for Fanconi anemia. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 21 Suppl 2 (1998) 24-27
11. Larder R., Chang L., Clinton M., et al. Gonadotropin-releasing hormone regulates expression of the DNA damage repair gene Fanconi anemia A, in pituitary gonadotroph cells. Biol. Reprod. 3 (2004) 828-836
12. Lawson Wilkins Pediatric Endocrine Society (LWPES) Writing Committee. Growth hormone treatment and neoplasia: coincidence or consequence?. J. Clin. Endocrinol. Metab. 87 (2002) 5351-5352
13. Massa G.G., Heinrichs C., Vamos E., et al. Hypergonadotropic hypogonadism in boy with Fanconi anemia with growth hormone deficiency and pituitary stalk interruption. J. Pediatr. 2 (2002) 277
14. Moustacchi E. L'anémie de Fanconi. Encyclopédie Orphanet. Octobre 2003. (www.orpha.net).
15. Nadler J.J., and Braun R.E. Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells. Genesis 27 (2000) 117-123
16. Reichlin S. Neuroendocrinology. In: Wilson J.D., Foster D.W., Kronenberg H., and Larsen P.R. (Eds). Williams textbook of Endocrinology 9th edition (1998), Éd Saunders, Philadelphia 165-248
17. Reynaud R., Barlier A., Chadli-Chaieb M., et al. Hypopituitarisme congénital. Quand analyser les gènes de facteurs de transcription?. Presse Med. 33 (2004) 400-405
18. Stahnke N. Leukemia in growth-hormone-related patients: an update. Horm. Res. 38 suppl 1 (1992) 56-62
19. Taniguchi T, D'Andrea AD. The molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006 Feb 21;[Epub ahead of print].
20. The Growth Hormone Research Society 2001 Consensus. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 86 (2001) 1868-1870
21. Thomas P.Q., Dattani M.T., Brickman J.M., et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum. Mol. Genet. 10 (2001) 39-45
22. Tischkowitz M., and Inderjeet D. Fanconi anaemia and leukemia- clinical and molecular aspects. BJ Haematol 126 (2004) 176-191
23. Touraine P., and Goffin V. Physiologie de la prolactine. EMC-Endocrinologie 2 (2005) 50-76
24. Vallette-Kasic S., Netchine I., Reynaud R., et al. Causes génétiques de déficit en hormone de croissance. Mte 4 (2002) 15-22
25. Wada E., Murata M., and Watanabe S. Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi's anemia. Jpn. J. Clin. Oncol. 1 (1989) 36-39 [abstract]
26. Wajnrajch M.P., Gertner J.M., Huma Z., et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 107 (2001) 744-754
27. Watanabe S., Mizuno S., Oshima L.H., et al. Leukemia and other malignancies among GH users. J. Pediatr. Endocrinol. 1 (1993) 99-108